Reid Alexander Waldman - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MANE
Reported as of: 03 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Feb 2026, 19:00:10 UTC
Next SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Greco, Attorney-in-Fact

Key filing fact

Reid Alexander Waldman filed Form 4 for Veradermics, Inc (MANE) on 05 Feb 2026.

Key facts

This page summarizes Reid Alexander Waldman's Form 4 filing for Veradermics, Inc (MANE).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Feb 2026, 19:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002107415 Primary reporting owner

Waldman Reid Alexander

Relationship: Chief Executive Officer, Director
Address: C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN
Signature: /s/ Michael Greco, Attorney-in-Fact
Signature date: 05 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MANE transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,437
Change %: +0.62%
Price
Shares after: 234,872
Date: 05 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MANE transaction Derivative

Series A Convertible Preferred Stock

Conversion of derivative security

Transaction value
Shares: -1,437
Change %: -100%
Price
Shares after: 0
Date: 05 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,437
Exercise price
Footnotes: F1

MANE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +556,399
Change %
Price: $0.000000
Shares after: 556,399
Date: 03 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 556,399
Exercise price: $17.00
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

Footnote F2

The option vests as to 25% of the underlying shares of Common Stock on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.